Method for inhibiting helicobacter pylori by radix astragali, radix scutellariae and herba artemisiae scopariae decoction
Through the multi-target and multi-path synergistic effect of Qilianqinying Decoction, the drug resistance and side effects in the treatment of Helicobacter pylori are solved, and a safe and effective treatment plan is provided for different groups of people, especially for the elderly. Special groups such as pregnant women and breastfeeding women.
Patent Information
- Application Number
- CN202411032314.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-08
AI Technical Summary
The existing treatment methods for Helicobacter pylori have problems such as increased drug resistance, greater side effects of drugs and unsuitable for special groups. In particular, the widespread use of antibiotics leads to increased drug resistance, and are special groups such as the elderly, pregnant women and lactating women. Side effects are greater.
Qilianqinying Decoction is used, which includes Astragalus, Coptis chinensis, Scutellaria baicalensis, Pinellia ternata, Magnolia officinalis and Dandelion. Through the synergistic effect of multiple targets and multiple pathways, it prevents the growth and reproduction of Helicobacter pylori. The preparation method includes fine grinding. , soak, decoct and concentrate, and determine the minimum inhibitory concentration of 25-35g/L, suitable for patients of different ages and physiques.
Effectively prevent the growth and reproduction of Helicobacter pylori, reduce drug resistance, and have a low risk of side effects. It is suitable for special groups such as the elderly, pregnant women and breastfeeding women who are not suitable for antibiotic treatment. No significant drug resistance is seen after long-term use. , solves the side effects and drug resistance problems of traditional treatment plans.
Smart Images

Figure CN118909852A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of Chinese medicine compound preparations and application thereof, and specifically to a method for inhibiting Helicobacter pylori by Qilianqinying Decoction. Background Art
[0002] Helicobacter pylori (Hp) is a Gram-negative bacterium that is widely present in the human gastric mucosa. It is an important pathogen that causes a variety of gastrointestinal diseases such as chronic gastritis, peptic ulcers, and gastric cancer. The transmission routes of Helicobacter pylori infection mainly include oral-oral transmission and fecal-oral transmission, and it is highly contagious. At present, more than half of the world's population is infected with Helicobacter pylori, especially in developing countries, where the infection rate is even higher, and has become a major global public health issue.
[0003] The main existing method for treating Helicobacter pylori infection is triple or quadruple therapy with antibiotics combined with proton pump inhibitors. Although these treatment options have a good clearance effect on Helicobacter pylori in the short term, long-term use will lead to a series of problems. First, the widespread use of antibiotics has led to a gradual increase in the drug resistance of Helicobacter pylori, resulting in a decline in the treatment effect year by year. Secondly, antibiotics and proton pump inhibitors have large side effects, and patients often experience adverse reactions such as nausea, vomiting, and diarrhea during treatment, which seriously affects the quality of life of patients. In addition, some patients are still at risk of recurrence after completing standard treatment and require multiple treatments, which increases the complexity and cost of treatment.
[0004] In view of the limitations of existing treatment methods, researchers have begun to explore new treatment approaches in order to find an effective and safe treatment method. To this end, the present invention proposes a method for inhibiting Helicobacter pylori with Qilianqinying Decoction. Summary of the invention
[0005] In view of the deficiencies in the prior art, the present invention provides a method for inhibiting Helicobacter pylori with Qilianqinying Decoction, which solves the problems of increased drug resistance, severe drug side effects and unsuitability for use by special populations in the existing treatment regimens.
[0006] To achieve the above objectives, the present invention is implemented through the following technical scheme: a method for inhibiting Helicobacter pylori with Qilianqinying Decoction, comprising the following steps:
[0007] S1. Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum;
[0008] S2. Prepare Qilianqinying Decoction according to a certain weight ratio range:
[0009] S3, each Chinese herbal medicine slice is cut into small pieces and ground, soaked in water 8-12 times the volume of the herbal medicine for 1-2h, decocted three times, decocted for 25-35min, 25-35min and 15-25min respectively, filtered out the medicinal solution, combined, evaporated and concentrated at normal pressure until the ratio of the original medicinal material mass to the decoction volume is 1:1;
[0010] S4. Determine the minimum inhibitory concentration of Qilianqinying Decoction against Helicobacter pylori by agar dilution method. The minimum inhibitory concentration is 25-35 g / L.
[0011] S5. Dilute Helicobacter pylori to 0.4-0.6 McFarland turbidimetric units and then dilute again at a ratio of 1:5 to 1:15 to prepare three drug concentration culture media, inoculate and culture, take samples and dilute and inoculate at 0, 5-7, and 23-25 hours at 35-39°C, and count the colonies after culturing at 35-39°C for 22-26 hours.
[0012] Preferably, the Qilianqinying Decoction is prepared in step S2 according to the following weight ratio: 10-20g of Astragalus, 10-20g of Coptis, 10-20g of Scutellaria, 5-15g of Pinellia, 5-15g of Magnolia officinalis, and 10-30g of Taraxacum.
[0013] Preferably, the step S3 specifically includes the following steps:
[0014] S3.1, soaking: cut each Chinese herbal medicine into small pieces and grind them, and soak them in water 8-12 times the volume of the herbal medicine for 1-2 hours;
[0015] S3.2, first decoction: decoct the soaked herbs for 25-35 minutes and filter out the liquid;
[0016] S3.3, Second decoction: Add water to submerge the herbs by 3-4 cm, decoct for 25-35 min, and filter out the liquid;
[0017] S3.4, third decoction: add water to submerge the herbs by 1-1.5cm, decoct for 15-25min, and filter out the liquid;
[0018] S3.5. Combination and concentration: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0019] Preferably, the step S4 specifically includes the following steps:
[0020] S4.1. Prepare drug agar medium;
[0021] S4.2, Inoculation of bacterial solution:
[0022] The test bacteria were diluted to a concentration of 10 6 -10 8 CFU / ml bacterial suspension;
[0023] Use a micropipette to draw 0.5-1.5 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 3 -10 5 individual bacteria;
[0024] S4.3, Cultivation and Observation:
[0025] Incubate the plate upside down in a 35°C incubator for 16-20 hours;
[0026] The lowest drug concentration at which no obvious bacterial growth was observed with the naked eye was defined as the minimum inhibitory concentration.
[0027] Preferably, the preparation of the drug agar medium in step S4.1 specifically comprises the following steps:
[0028] S4.11. Prepare culture medium:
[0029] Prepare several conical flasks and add 20-30 ml of melted broth agar medium to each flask;
[0030] S4.12, dilution of the drug solution:
[0031] Add 20-30 ml of 100% Chinese medicine decoction to the first flask to make its concentration 0.4-0.6 g / ml;
[0032] After mixing, take out 20-30 ml and add it to the second flask, and then dilute it in multiples until the required concentration range of 25-35 g / L is reached.
[0033] Preferably, the step S5 specifically includes the following steps:
[0034] S5.1. Preparation of bacterial suspension:
[0035] Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.4-0.6 McFarland turbidimetric units and a bacterial count of 1.0-2.0×10 8 CFU / ml;
[0036] Then dilute it at a ratio of 1:5 to 1:15 to make the bacterial count 1.0-2.0×10 7 CFU / ml for future use;
[0037] S5.2, preparing three culture media with different drug concentrations;
[0038] S5.3. Inoculation and cultivation of bacterial suspension:
[0039] Add an equal amount of bacterial suspension to each concentration of culture medium;
[0040] Place in an incubator at 35-39°C;
[0041] S5.4 Sampling and dilution:
[0042] Samples were taken at 0 hours, 5-7 hours, and 23-25 hours;
[0043] Dilute the sample at a ratio of 1:5 to 1:15;
[0044] S5.5. Inoculation and cultivation of diluted bacterial solution:
[0045] Inoculate the diluted bacterial solution into nutrient agar medium;
[0046] Spread evenly and incubate at 35-39℃ for 22-26h;
[0047] S5.6. Colony count:
[0048] Colonies were counted after 22-26 hours of incubation.
[0049] Preferably, the three culture media with different drug concentrations in step S5.2 are prepared by preparing broth culture media with drug concentrations of 0.4×MIC-0.6×MIC, 0.8×MIC-1.2×MIC and 1.8×MIC-2.2×MIC.
[0050] The present invention provides a method for inhibiting Helicobacter pylori with Qilianqinying decoction, which has the following beneficial effects:
[0051] 1. The Qilianqinying decoction of the present invention is composed of astragalus, coptis, scutellaria, pinellia, magnolia bark and dandelion, each of which has a different pharmacological effect. It can effectively prevent the growth and reproduction of Helicobacter pylori and reduce the occurrence of drug resistance through multi-target and multi-pathway synergistic effects.
[0052] 2. The Qilianqinying Decoction of the present invention is a traditional Chinese medicine compound, suitable for patients of different age groups and physical constitutions, especially for special groups such as the elderly, pregnant women and lactating women who are not suitable for antibiotic treatment. It has a lower risk of side effects and no significant drug resistance is observed during long-term use, effectively solving the problems of side effects and drug resistance that are often accompanied by traditional triple or quadruple antibiotic treatment regimens. BRIEF DESCRIPTION OF THE DRAWINGS
[0053] Figure 1 is a flow chart of the present invention;
[0054] Figure 2 are representative immunohistochemical images of gastric mucosa in each group of the present invention;
[0055] Figure 3 The expression diagram of NF-kB in gastric mucosa of each group of the present invention;
[0056] Figure 4 This is a bactericidal curve diagram of the Qilianqinying decoction of the present invention against Helicobacter pylori. DETAILED DESCRIPTION
[0057] The technical solution of the present invention will be described clearly and completely below in conjunction with the accompanying drawings of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0058] Example:
[0059] Please see attached Figure 1 The embodiment of the present invention provides a method for inhibiting Helicobacter pylori with Qilianqinying Decoction, comprising the following steps:
[0060] S1. Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum;
[0061] S2. Prepare Qilianqinying Decoction according to a certain weight ratio range:
[0062] S3, each Chinese herbal medicine slice is cut into small pieces and ground, soaked in water 8-12 times the volume of the herbal medicine for 1-2h, decocted three times, decocted for 25-35min, 25-35min and 15-25min respectively, filtered out the medicinal solution, combined, evaporated and concentrated at normal pressure until the ratio of the original medicinal material mass to the decoction volume is 1:1;
[0063] S4. Determine the minimum inhibitory concentration of Qilianqinying Decoction against Helicobacter pylori by agar dilution method. The minimum inhibitory concentration is 25-35 g / L.
[0064] S5. Dilute Helicobacter pylori to 0.4-0.6 McFarland turbidimetric units and then dilute again at a ratio of 1:5 to 1:15 to prepare three drug concentration culture media, inoculate and culture, take samples and dilute and inoculate at 0, 5-7, and 23-25 hours at 35-39°C, and count the colonies after culturing at 35-39°C for 22-26 hours.
[0065] In step S2, the Qilianqinying decoction is prepared according to the following weight ratio: 10-20g of Astragalus, 10-20g of Coptis, 10-20g of Scutellaria, 5-15g of Pinellia, 5-15g of Magnolia officinalis, and 10-30g of Taraxacum.
[0066] The S3 step specifically includes the following steps:
[0067] S3.1, soaking: cut each Chinese herbal medicine into small pieces and grind them, and soak them in water 8-12 times the volume of the herbal medicine for 1-2 hours;
[0068] S3.2, first decoction: decoct the soaked herbs for 25-35 minutes and filter out the liquid;
[0069] S3.3, Second decoction: Add water to submerge the herbs by 3-4 cm, decoct for 25-35 min, and filter out the liquid;
[0070] S3.4, third decoction: add water to submerge the herbs by 1-1.5cm, decoct for 15-25min, and filter out the liquid;
[0071] S3.5. Combination and concentration: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0072] The S4 step specifically includes the following steps:
[0073] S4.1. Prepare drug agar medium;
[0074] S4.2, Inoculation of bacterial solution:
[0075] The test bacteria were diluted to a concentration of 10 6 -10 8 CFU / ml bacterial suspension;
[0076] Use a micropipette to draw 0.5-1.5 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 3 -10 5 individual bacteria;
[0077] S4.3, Cultivation and Observation:
[0078] Incubate the plate upside down in a 35°C incubator for 16-20 hours;
[0079] The lowest drug concentration at which no obvious bacterial growth was observed with the naked eye was defined as the minimum inhibitory concentration.
[0080] The preparation of the drug agar medium in step S4.1 specifically comprises the following steps:
[0081] S4.11. Prepare culture medium:
[0082] Prepare several conical flasks and add 20-30 ml of melted broth agar medium to each flask;
[0083] S4.12, dilution of the drug solution:
[0084] Add 20-30 ml of 100% Chinese medicine decoction to the first flask to make its concentration 0.4-0.6 g / ml;
[0085] After mixing, take out 20-30 ml and add it to the second flask, and then dilute it in multiples until the required concentration range of 25-35 g / L is reached.
[0086] Step S5 specifically includes the following steps:
[0087] S5.1. Preparation of bacterial suspension:
[0088] Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.4-0.6 McFarland turbidimetric units and a bacterial count of 1.0-2.0×10 8 CFU / ml;
[0089] Then dilute it at a ratio of 1:5 to 1:15 to make the bacterial count 1.0-2.0×10 7 CFU / ml for future use;
[0090] S5.2, preparing three culture media with different drug concentrations;
[0091] S5.3. Inoculation and cultivation of bacterial suspension:
[0092] Add an equal amount of bacterial suspension to each concentration of culture medium;
[0093] Place in an incubator at 35-39°C;
[0094] S5.4 Sampling and dilution:
[0095] Samples were taken at 0 hours, 5-7 hours, and 23-25 hours;
[0096] Dilute the sample at a ratio of 1:5 to 1:15;
[0097] S5.5. Inoculation and cultivation of diluted bacterial solution:
[0098] Inoculate the diluted bacterial solution into nutrient agar medium;
[0099] Spread evenly and incubate at 35-39℃ for 22-26h;
[0100] S5.6. Colony count:
[0101] Colonies were counted after 22-26 hours of incubation.
[0102] The three culture media with different drug concentrations in step S5.2 are used to prepare broth culture media with drug concentrations of 0.4×MIC-0.6×MIC, 0.8×MIC-1.2×MIC and 1.8×MIC-2.2×MIC.
[0103] Example 1
[0104] step:
[0105] S1: Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum.
[0106] S2: Prepare Qilianqinying Decoction according to the following weight proportions: 10g Astragalus, 10g Coptis, 10g Scutellaria, 5g Pinellia, 5g Magnolia, and 10g Taraxacum.
[0107] S3:
[0108] S3.1: Cut and grind each Chinese herbal medicine into small pieces and soak them in water 8 times the volume of the herbal medicine for 1 hour;
[0109] S3.2: Boil the soaked herbs for 25 minutes and filter out the liquid;
[0110] S3.3: Add water to submerge the herbs to 3 cm, boil for 25 min, and filter out the liquid;
[0111] S3.4: Add water to submerge the herbs to 1 cm, boil for 15 min, and filter out the liquid;
[0112] S3.5: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0113] S4:
[0114] S4.1: Prepare drug agar medium;
[0115] S4.2: Dilute the test bacteria to a concentration of 1.0×10 8 CFU / ml bacterial suspension;
[0116] S4.3: Use a micropipette to draw 1.0 μl and inoculate it on the drug-containing plate. The final inoculation volume contains about 10^4 bacteria per inoculation point.
[0117] S4.4: Place the plate upside down in a 35°C incubator and incubate for 16 hours;
[0118] S4.5: Observation results: the lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the minimum inhibitory concentration, which ranges from 25g / L.
[0119] S5:
[0120] S5.1: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.4 McFarland turbidimetric unit and the bacterial count is 1.0×10 8 CFU / ml;
[0121] S5.2: Dilute again at a ratio of 1:5 to make the bacterial count 1.0×10 7 CFU / ml for future use;
[0122] S5.3: Prepare three culture media with different drug concentrations;
[0123] S5.4: Add an equal amount of bacterial suspension to each concentration of culture medium;
[0124] S5.5: Place in a 35°C incubator;
[0125] S5.6: Sample at 0 hours, 5 hours, and 23 hours;
[0126] S5.7: Dilute the sample 1:5;
[0127] S5.8: Inoculate the diluted bacterial solution into nutrient agar medium;
[0128] S5.9: Spread evenly and incubate at 35°C for 22 hours;
[0129] S5.10: Count the colonies after 22 hours of incubation.
[0130] Summary: This example verifies the effective inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at the lowest concentration of 25 g / L through specific parameter settings.
[0131] Example 2
[0132] step:
[0133] S1: Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum.
[0134] S2: Prepare Qilianqinying Decoction according to the following weight proportions: 15g Astragalus, 15g Coptis, 15g Scutellaria, 10g Pinellia, 10g Magnolia, and 15g Taraxacum.
[0135] S3:
[0136] S3.1: Cut and grind each Chinese herbal medicine into small pieces and soak them in water 10 times the volume of the herbal medicine for 1.5 hours;
[0137] S3.2: Boil the soaked herbs for 30 min and filter out the liquid;
[0138] S3.3: Add water to submerge the herbs by 3.5 cm, boil for 30 min, and filter out the liquid;
[0139] S3.4: Add water to submerge the herbs to 1.2 cm, boil for 20 min, and filter out the liquid;
[0140] S3.5: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0141] S4:
[0142] S4.1: Prepare drug agar medium;
[0143] S4.2: Dilute the test bacteria to a concentration of 1.5×10 8 CFU / ml bacterial suspension;
[0144] S4.3: Use a micropipette to draw 1.0 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 4 individual bacteria;
[0145] S4.4: Place the plate upside down in a 37°C incubator and incubate for 18 hours;
[0146] S4.5: Observation results: the lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the minimum inhibitory concentration, which ranges from 30g / L.
[0147] S5:
[0148] S5.1: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.5 McFarland turbidimetric unit, with a bacterial count of 1.5×10 8 CFU / ml;
[0149] S5.2: Dilute again at a ratio of 1:10 to make the bacterial count 1.5×10 7 CFU / ml for future use;
[0150] S5.3: Prepare three culture media with different drug concentrations;
[0151] S5.4: Add an equal amount of bacterial suspension to each concentration of culture medium;
[0152] S5.5: Place in a 37°C incubator;
[0153] S5.6: Sample at 0 hours, 6 hours, and 24 hours;
[0154] S5.7: Dilute the sample 1:10;
[0155] S5.8: Inoculate the diluted bacterial solution into nutrient agar medium;
[0156] S5.9: Spread evenly and incubate at 37°C for 24 hours;
[0157] S5.10: Count the colonies after 24 hours of incubation.
[0158] Summary: This example verifies the effective inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at a concentration of 30 g / L by setting parameters in a medium concentration range.
[0159] Example 3
[0160] step:
[0161] S1: Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum.
[0162] S2: Prepare Qilianqinying Decoction according to the following weight proportions: 20g Astragalus, 20g Coptis, 20g Scutellaria, 15g Pinellia, 15g Magnolia, and 30g Taraxacum.
[0163] S3:
[0164] S3.1: Cut and grind each Chinese herbal medicine into small pieces and soak them in water 12 times the volume of the herbal medicine for 2 hours;
[0165] S3.2: Boil the soaked herbs for 35 minutes and filter out the liquid;
[0166] S3.3: Add water to submerge the herbs to 4 cm, boil for 35 min, and filter out the liquid;
[0167] S3.4: Add water to submerge the herbs to 1.5 cm, boil for 25 min, and filter out the liquid;
[0168] S3.5: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0169] S4:
[0170] S4.1: Prepare drug agar medium;
[0171] S4.2: Dilute the test bacteria to a concentration of 2.0×10 8 CFU / ml bacterial suspension;
[0172] S4.3: Use a micropipette to draw 1.5 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 5 individual bacteria;
[0173] S4.4: Place the plate upside down in a 39°C incubator and incubate for 20 hours;
[0174] S4.5: Observation results: the lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the minimum inhibitory concentration, which ranges from 35g / L.
[0175] S5:
[0176] S5.1: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.6 McFarland turbidimetric unit, with a bacterial count of 2.0×10 8 CFU / ml;
[0177] S5.2: Dilute again at a ratio of 1:15 to a bacterial count of 2.0×10 7 CFU / ml for future use;
[0178] S5.3: Prepare three culture media with different drug concentrations;
[0179] S5.4: Add an equal amount of bacterial suspension to each concentration of culture medium;
[0180] S5.5: Place in a 39°C incubator;
[0181] S5.6: Take samples at 0 hours, 7 hours, and 25 hours;
[0182] S5.7: Dilute the sample 1:15;
[0183] S5.8: Inoculate the diluted bacterial solution into nutrient agar medium;
[0184] S5.9: Spread evenly and incubate at 39°C for 26 hours;
[0185] S5.10: Count the colonies after 26 hours of incubation.
[0186] Summary: This example verifies the effective inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at a concentration of 35 g / L by setting the parameters of the maximum concentration range.
[0187] Example 4
[0188] step:
[0189] S1: Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum.
[0190] S2: Prepare Qilianqinying Decoction according to the following weight proportions: 12g Astragalus, 12g Coptis, 12g Scutellaria, 8g Pinellia, 8g Magnolia, and 12g Taraxacum.
[0191] S3:
[0192] S3.1: Cut and grind each Chinese herbal medicine into small pieces and soak them in water 9 times the volume of the herbal medicine for 1.2 hours;
[0193] S3.2: Boil the soaked herbs for 28 minutes and filter out the liquid;
[0194] S3.3: Add water to submerge the herbs by 3.2 cm, boil for 28 min, and filter out the liquid;
[0195] S3.4: Add water to submerge the herbs to 1.3 cm, boil for 18 min, and filter out the liquid;
[0196] S3.5: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0197] S4:
[0198] S4.1: Prepare drug agar medium;
[0199] S4.2: Dilute the test bacteria to a concentration of 1.2×10 8 CFU / ml bacterial suspension;
[0200] S4.3: Use a micropipette to draw 0.8 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 4 individual bacteria;
[0201] S4.4: Place the plate upside down in a 36°C incubator and incubate for 17 hours;
[0202] S4.5: Observation results: the lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the minimum inhibitory concentration, which ranges from 27g / L.
[0203] S5:
[0204] S5.1: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.45 McFarland turbidimetric units, with a bacterial count of 1.2×10 8 CFU / ml;
[0205] S5.2: Dilute again at a ratio of 1:7 to a bacterial count of 1.2×10 7 CFU / ml for future use;
[0206] S5.3: Prepare three culture media with different drug concentrations;
[0207] S5.4: Add an equal amount of bacterial suspension to each concentration of culture medium;
[0208] S5.5: Place in a 36°C incubator;
[0209] S5.6: Sample at 0 hours, 6 hours, and 24 hours;
[0210] S5.7: Dilute the sample at a ratio of 1:7;
[0211] S5.8: Inoculate the diluted bacterial solution into nutrient agar medium;
[0212] S5.9: Spread evenly and incubate at 36°C for 24 hours;
[0213] S5.10: Count the colonies after 24 hours of incubation.
[0214] Summary: This example verifies the effective inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at a concentration of 27 g / L by setting parameters in a lower concentration range.
[0215] Example 5
[0216] step:
[0217] S1: Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum.
[0218] S2: Prepare Qilianqinying Decoction according to the following weight proportions: 18g Astragalus, 18g Coptis, 18g Scutellaria, 12g Pinellia, 12g Magnolia, and 25g Taraxacum.
[0219] S3:
[0220] S3.1: Cut and grind each Chinese herbal medicine into small pieces and soak them in water 11 times the volume of the herbal medicine for 1.8 hours;
[0221] S3.2: Boil the soaked herbs for 32 minutes and filter out the liquid;
[0222] S3.3: Add water to submerge the herbs by 3.8 cm, boil for 32 min, and filter out the liquid;
[0223] S3.4: Add water to submerge the herbs to 1.4 cm, boil for 22 min, and filter out the liquid;
[0224] S3.5: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:1.
[0225] S4:
[0226] S4.1: Prepare drug agar medium;
[0227] S4.2: Dilute the test bacteria to a concentration of 1.8×10 8 CFU / ml bacterial suspension;
[0228] S4.3: Use a micropipette to draw 1.2 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 5 individual bacteria;
[0229] S4.4: Place the plate upside down in a 38°C incubator and incubate for 19 hours;
[0230] S4.5: Observation results: the lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the minimum inhibitory concentration, which ranges from 32g / L.
[0231] S5:
[0232] S5.1: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.55 McFarland turbidimetric units, with a bacterial count of 1.8×10 8 CFU / ml;
[0233] S5.2: Dilute again at a ratio of 1:12 to a bacterial count of 1.8×10 7 CFU / ml for future use;
[0234] S5.3: Prepare three culture media with different drug concentrations;
[0235] S5.4: Add an equal amount of bacterial suspension to each concentration of culture medium;
[0236] S5.5: Place in a 38°C incubator;
[0237] S5.6: Sample at 0 hours, 6 hours, and 24 hours;
[0238] S5.7: Dilute the sample 1:12;
[0239] S5.8: Inoculate the diluted bacterial solution into nutrient agar medium;
[0240] S5.9: Spread evenly and incubate at 38°C for 24 hours;
[0241] S5.10: Count the colonies after 24 hours of incubation.
[0242] Summary: This example verifies the effective inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at a concentration of 32 g / L by setting parameters in the medium and high concentration range.
[0243] Summary
[0244] Through the above five examples, it is verified that Qilianqinying Decoction has a significant inhibitory effect on Helicobacter pylori, and exhibits good antibacterial performance under different concentration ranges and parameter settings. Specifically:
[0245] Examples 1 to 5 cover different weight proportions and preparation parameter ranges of Qilianqinying Decoction, from lower to higher concentration settings, and all demonstrate effective inhibitory effects on Helicobacter pylori.
[0246] In each example, the stability and effectiveness of Qilianqinying Decoction under different preparation conditions were demonstrated through different soaking time, decoction time and temperature parameters.
[0247] The minimum inhibitory concentration was in the range of 25 g / L to 35 g / L, and Qilianqinying Decoction showed good antibacterial effect, proving the effectiveness of this Chinese medicine compound under various conditions.
[0248] In summary of the five embodiments, the method for inhibiting Helicobacter pylori with Qilianqinying Decoction of the present invention has a significant antibacterial effect, a wide range of applications, and can provide an effective and safe traditional Chinese medicine solution for clinical treatment.
[0249] Please see attached Figure 2 -Attached Figure 4 In order to verify that the Qilianqinying decoction prepared by the present invention has the effect of inhibiting Helicobacter pylori, the following two experiments were designed:
[0250] Experiment 1: In vivo antibacterial experiment of Qilianqinying Decoction on Helicobacter pylori
[0251] Objective: To verify the in vivo antibacterial effect of Qilianqinying decoction on mice infected with Helicobacter pylori and to evaluate its anti-inflammatory and Helicobacter pylori eradication potential.
[0252] Experimental steps:
[0253] Preparation of Qilianqinying Decoction:
[0254] Recipe: 15g Astragalus, 15g Coptis, 15g Scutellaria, 9g Pinellia, 10g Magnolia, 20g Taraxacum.
[0255] Experimental equipment: experimental mice, electronic balance, slice crusher, evaporation equipment, incubator, micropipette, sterile saline, urease kit, immunohistochemistry kit, microscope.
[0256] method:
[0257] Cut each Chinese herbal medicine into small pieces and grind them into small pieces, then soak them in water 10 times the volume of the herbal medicine for 1-2 hours.
[0258] Boil the soaked herbs for 30 minutes and filter out the liquid.
[0259] Add water to submerge the herbs by 3-4 cm, boil for 30 minutes, and filter out the liquid.
[0260] Add water to submerge the herbs by 1-1.5 cm, boil for 20 minutes, and filter out the liquid.
[0261] The three filtrates were combined, evaporated at normal pressure, concentrated to a ratio of original medicinal material mass to decoction volume of 1:1 and a concentration of 100 g / 100 ml, sterilized, and stored in a 4°C refrigerator.
[0262] Experimental Animal Handling:
[0263] Animals: 44 SPF grade C57BL / 6 mice, 4-6 weeks old, weighing about 16-18 g, male.
[0264] Grouping: The mice were randomly divided into four groups, with 11 mice in each group, namely the normal group, the model group, the Chinese medicine group and the Western medicine group.
[0265] Modeling:
[0266] Except for the normal group, the mice in the other three groups were fasted for 12 hours and gavaged with 0.5 ml of 5% NaHCO3 solution.
[0267] After 24 hours, 0.5 ml of active Helicobacter pylori solution (1×10^9 CFU / ml) was inoculated and the inoculation continued for 5 days.
[0268] Pharmacological interventions:
[0269] Chinese medicine group: gavage 0.5 ml of Qilianqinying decoction daily for 14 consecutive days.
[0270] Western medicine group: gavage 0.5 ml of triple drug (omeprazole 20 mg, clarithromycin 500 mg, amoxicillin 1000 mg) daily for 14 consecutive days.
[0271] Normal group and model group: 0.5 ml of normal saline was gavaged daily for 14 consecutive days.
[0272] Sampling and analysis:
[0273] Eradication evaluation: The mice were killed, and the stomach was removed by laparotomy. The stomach was cut open along the greater curvature and rinsed with 4°C saline. Part of the gastric antrum was taken for urease test (RUT). The remaining part of the gastric antrum-gastric body tissue was fixed with paraformaldehyde, embedded in paraffin, and sliced for HE and Warthin-Starry staining. The double standard was used, and Hp eradication was determined only when the urease test and pathological staining were both negative.
[0274] Anti-inflammatory analysis: Immunohistochemistry was used to determine the positive expression of NF-κB in the gastric mucosa to evaluate the anti-inflammatory effect of the drug. The paraffin sections were dewaxed and hydrated, and antigen repair was performed under high pressure. After being slightly dried, the tissue area to be tested on the slide was circled with an immunohistochemistry pen, and peroxidase blocking solution was added. The samples were incubated at room temperature for 30 minutes, rinsed with PBS for 3×5 minutes, and then the blocking solution was added. The samples were incubated at room temperature for 1 hour. The blocking solution was removed, and the primary antibody (prepared with IFN-y antibody at a ratio of 1:100, 200 μL / sample) was added and incubated at 4°C overnight. Rinse with PBS for 3×5min, add secondary antibody (biotin-labeled goat anti-rabbit IgG complex, biotin-labeled goat anti-rabbit IgG polymer prepared at a ratio of 1:100, 200μL / sample dropwise), incubate at room temperature for 1 hour, rinse with PBS for 3×5min, add streptavidin-peroxidase, incubate at room temperature for 30 minutes, rinse with PBS for 3×5min, discard PBS solution, add 200μL / sample freshly prepared DAB colorimetric solution to each slice, incubate at room temperature for 2min, observe under a microscope for 3-10min, react until it turns brown-yellow, rinse with tap water to neutralize, counterstain with hematoxylin, and rinse with tap water to turn blue for 10min. Place the slices in a 60℃ oven and bake for 1 minute. Seal with neutral gum. Collect at 400x field of view.
[0275] result:
[0276] HP eradication rate
[0277] Ten mice were included in the data analysis in each group. The number of negative rapid urease tests in each group was: 10 in the normal group, 0 in the model group, 6 in the Chinese medicine group, and 8 in the Western medicine group; the number of negative histopathological staining in each group was: 10 in the normal group, 0 in the model group, 6 in the Chinese medicine group, and 7 in the Western medicine group. Combining the two detection methods, the eradication rates of Helicobacter pylori were: 100% in the normal group, 0% in the model group, 60% in the Chinese medicine group, and 70% in the Western medicine group. The Chinese medicine group and the Western medicine group were compared by the chi-square test and Fisher's exact probability method, P = 1, and there was no statistically significant difference (see Table 1)
[0278] Table 1 HP eradication rate in each group
[0279]
[0280] Expression of NF-kB in gastric mucosa
[0281] The brown-yellow cell granules are the positive cell expression sites, such as Figure 2 As can be seen, a small amount of NF-kB positive expression was observed in the gastric mucosa of mice in the normal group, the number of positive cells in the model group increased significantly, and the positive expression levels of the Chinese medicine group and the Western medicine group were between the normal group and the model group. Image-ProPlus6.0 software (Media Cybernetics, Inc., Rockville, MD, USA) was used for further precise analysis: the same brown color was selected as the unified standard for judging the positivity of all photos, and each photo was analyzed to obtain the positive area and integrated optical density value (IOD) of each photo, and the average protein expression intensity and positive rate were calculated (Note: average protein expression intensity = integrated optical density value / total area; positive rate = positive area / total area). The results are shown in Table 2 and Figure 3 The positive expression rate of gastric mucosal NF-kB: normal group (2.525±0.394) < Chinese medicine group (4.609±0.858) < Western medicine group (6.869±0.243) < model group (11.365±1.152), there were statistical differences among the groups (normal group VS Chinese medicine group P<0.05; normal group VS Western medicine group P<0.001; normal group VS model group P<0.0001; model group VS Chinese medicine group P<0.0001; model group VS Western medicine group P<0.001; Chinese medicine group VS Western medicine group P<0.05). This shows that the model was successfully established, and the drug played a role in inhibiting the positive expression of NF-kB, and Chinese medicine was superior to Western medicine.
[0282] Table 2 Expression of NF-kB in gastric mucosa of mice in each group (mean ± SD; n = 10)
[0283]
[0284] (Note: △ = normal group VS Chinese medicine group P < 0.05; ○ = normal group VS Western medicine group P < 0.001; ☆ = normal group VS model group P < 0.0001; * = model group VS Chinese medicine group P < 0.0001; # = model group VS Western medicine group P < 0.001; □ = Chinese medicine group VS Western medicine group P < 0.05)
[0285] Experimental analysis:
[0286] In this study, a mouse model of Helicobacter pylori (HP) infection was established, and the in vivo clearance effect of Qilianqinying Decoction on HP was comprehensively evaluated by rapid urease test and histopathological staining. The results showed that the HP eradication rate of the normal group was 100%, and that of the model group was 0%, indicating that there was no cross-infection between the groups and the model was successful. The HP eradication rate of the Chinese medicine group was 60%, and that of the Western medicine group was 70%, with no statistical difference between the two groups, indicating that both Qilianqinying Decoction and the Western medicine triple can effectively eradicate Helicobacter pylori, and the effect of Qilianqinying Decoction is close to that of the Western medicine triple.
[0287] This study used immunohistochemistry to determine the positive expression of NF-kB in gastric mucosa. The results showed that the normal group < Chinese medicine group < Western medicine group < model group, and there were statistical differences among the groups. The model group had the highest expression, indicating that NF-κB was in an activated state after Helicobacter pylori infection; the NF-kB expression levels of the Chinese medicine group and the Western medicine group were between the normal group and the model group, indicating that after drug treatment, NF-κB was inhibited and the inflammatory response of the gastric mucosa was alleviated. The NF-κB expression in the Chinese medicine group was lower than that in the Western medicine group, and there was a statistical difference, indicating that the anti-inflammatory effect of Qilianqinying Decoction was better than that of the Western medicine triple.
[0288] In summary:
[0289] Experimental summary: The experimental results show that Qilianqinying Decoction has a significant inhibitory effect on Helicobacter pylori in vivo, and its anti-inflammatory effect is better than that of the Western medicine group. The Helicobacter pylori eradication rate of the Chinese medicine group was 60%, which was close to that of the Western medicine group (70%), and the expression of NF-κB was significantly reduced, indicating that Qilianqinying Decoction has good potential in eradicating Helicobacter pylori and reducing gastric mucosal inflammatory response.
[0290] Experiment 2: In vitro antibacterial experiment of Qilianqinying Decoction on Helicobacter pylori
[0291] Experimental purpose: To determine the in vitro minimum inhibitory concentration (MIC) of Qilianqinying decoction against Helicobacter pylori and evaluate its in vitro antibacterial effect.
[0292] Experimental steps:
[0293] Preparation of Qilianqinying Decoction:
[0294] Recipe: 15g Astragalus, 15g Coptis, 15g Scutellaria, 9g Pinellia, 10g Magnolia, 20g Taraxacum.
[0295] Experimental equipment: Erlenmeyer flask, broth agar medium, Chinese herbal medicine slices, incubator, micropipette, sterile saline, plate, lactase, sugar, constant temperature incubator
[0296] method:
[0297] Cut each Chinese herbal medicine into small pieces and grind them into small pieces, then soak them in water 10 times the volume of the herbal medicine for 1-2 hours.
[0298] Boil the soaked herbs for 30 minutes and filter out the liquid.
[0299] Add water to submerge the herbs by 3-4 cm, boil for 30 minutes, and filter out the liquid.
[0300] Add water to submerge the herbs by 1-1.5 cm, boil for 20 minutes, and filter out the liquid.
[0301] The three filtrates were combined, evaporated at normal pressure, concentrated to a ratio of original medicinal material mass to decoction volume of 1:1 and a concentration of 100 g / 100 ml, sterilized, and stored in a 4°C refrigerator.
[0302] Preparation of bacterial solution:
[0303] After culturing Helicobacter pylori for 72 hours, the concentration of the bacterial solution was adjusted to 3×10^9 CFU / ml.
[0304] Take 90ml of 10% whole milk, add 5g of lactase, hydrolyze at 37℃ for 1 hour, add 10g of sugar, sterilize and degrease at 90-95℃, when cooled to 37℃, add 10ml of bacterial solution (final concentration is 1×10^9CFU / ml), and culture at 37℃ for 16 hours.
[0305] Determination of minimum inhibitory concentration (MIC):
[0306] Use the multiple dilution method to prepare drug-containing plates: take 10 conical flasks, add 25 ml of melted broth agar medium to each, add 25 ml of 100% Chinese medicine decoction to the first one to make its concentration 0.5 g / ml, mix well and take out 25 ml, and dilute it to 1.95 g / L in sequence.
[0307] The test bacteria were diluted to a concentration of 1.5×10^7 CFU / ml, 1 μl was aspirated with a micropipette and inoculated onto the drug-containing plate. The drug was cultured for 16-20 hours. The lowest drug concentration at which no obvious bacterial growth was observed with the naked eye was taken as MIC.
[0308] Time-killing curve drawing:
[0309] Broth culture medium with drug concentrations of 1×MIC and 2×MIC was obtained by serial dilution. 1 μl of the prepared bacterial suspension was aspirated with a micropipette, and samples were taken and diluted at 0 h, 6 h, and 24 h, respectively. Nutrient agar medium was inoculated and colonies were counted after 24 h of culture. A time-killing curve was drawn with time versus viable bacteria count (CFU / ml).
[0310] Experimental results:
[0311] Minimum inhibitory concentration (MIC) of drug
[0312] Prepare the drug agar medium test according to Table 3 and apply the corresponding concentration of bacterial solution. The lowest drug concentration at which no obvious bacterial growth is seen by the naked eye is the MIC. Qilianqinying Decoction has an in vitro inhibitory effect on Helicobacter pylori, and the minimum inhibitory concentration MIC value is 31.25g / L.
[0313] Table 3:
[0314]
[0315] Time-killing curve
[0316] The number of viable bacteria was the highest at 0h when the drug had not yet taken effect. At 6h and 24h, the number of viable bacteria at 1×MIC concentration was higher than that at 2×MIC. At 24h, the number of viable bacteria at 2×MIC concentration was 0, and all bacteria died ( Figure 4 ). At 6h, the bactericidal rate of 1×MIC drug concentration was 44.44%, and the bactericidal rate of 2×MIC drug concentration was 62.5%; at 24h, the bactericidal rate of 1×MIC drug concentration was 77.78%, and the bactericidal rate of 2×MIC drug concentration was 100% (Table 4). Explanation: Qilianqinying Decoction has a killing effect on HP, and its effect gradually increases with time. The bactericidal rate at each time point is proportional to the drug concentration.
[0317] Table 4:
[0318]
[0319] Experimental summary: The experimental results show that Qilianqinying Decoction has an in vitro inhibitory effect on Helicobacter pylori, with a minimum inhibitory concentration (MIC) of 31.25 g / L. The time-killing curve shows that the antibacterial effect of Qilianqinying Decoction gradually increases over time, and all bacteria die within 24 hours at a drug concentration of 2×MIC, indicating that Qilianqinying Decoction has a significant bactericidal effect on Helicobacter pylori.
[0320] In order to verify the inhibitory effects of the five embodiments of the present invention on Helicobacter pylori, the following test experiments were designed:
[0321] Purpose:
[0322] To verify the inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at different concentrations and under different preparation conditions, and to evaluate its antibacterial properties and application potential.
[0323] Experimental procedures
[0324] Preparation of Qilianqinying Decoction:
[0325] formula:
[0326] Example 1: Astragalus 10g, Coptidis 10g, Scutellaria 10g, Pinellia 5g, Magnolia officinalis 5g, Taraxacum mongolicum 10g.
[0327] Example 2: 15g Astragalus, 15g Coptis, 15g Scutellaria, 10g Pinellia, 10g Magnolia, 15g Taraxacum.
[0328] Example 3: 20g Astragalus, 20g Coptis, 20g Scutellaria, 15g Pinellia, 15g Magnolia, and 30g Taraxacum.
[0329] Example 4: Astragalus 12g, Coptidis 12g, Scutellaria 12g, Pinellia 8g, Magnolia officinalis 8g, Taraxacum 12g.
[0330] Example 5: 18g Astragalus, 18g Coptis, 18g Scutellaria, 12g Pinellia, 12g Magnolia, 25g Taraxacum.
[0331] Experimental equipment: Erlenmeyer flask, broth agar culture medium, Chinese herbal medicine pieces, incubator, micropipette, sterile saline, plate, lactase, sugar, constant temperature incubator.
[0332] method:
[0333] Cut each Chinese herbal medicine into small pieces and grind them into small pieces, then soak them in corresponding multiples of water.
[0334] The decoction was carried out three times according to the time and volume in the example, and the filtrates were combined.
[0335] Evaporate at normal pressure and concentrate to a ratio of original medicinal material mass to decoction volume of 1:1, with a concentration of 100g / 100ml. Sterilize and store in a 4°C refrigerator.
[0336] Preparation of drug agar medium:
[0337] Prepare several Erlenmeyer flasks and add 25 ml of melted broth agar medium to each flask.
[0338] Add 25 ml of 100% Chinese herbal medicine decoction into the first flask to make its concentration 0.5 g / ml.
[0339] After mixing, take out 25 ml and add it to the second flask, and dilute it in series until the desired concentration range is reached (Example 1: 25 g / L, Example 2: 30 g / L, Example 3: 35 g / L, Example 4: 27 g / L, Example 5: 32 g / L).
[0340] Inoculation solution:
[0341] The standard strain of Helicobacter pylori was diluted to different concentrations (Example 1: 1.0×10^8 CFU / ml, Example 2: 1.5×10^8 CFU / ml, Example 3: 2.0×10^8 CFU / ml, Example 4: 1.2×10^8 CFU / ml, Example 5: 1.8×10^8 CFU / ml).
[0342] Dilute the bacterial solution according to the corresponding proportion and set aside.
[0343] Determination of minimum inhibitory concentration (MIC):
[0344] Use a micropipette to draw bacterial solution of corresponding concentration and inoculate it onto the drug-containing plate.
[0345] Incubate the plate upside down at the appropriate temperature.
[0346] The lowest drug concentration at which no obvious bacterial growth was observed with the naked eye was defined as the minimum inhibitory concentration.
[0347] Time-killing curve drawing:
[0348] Broth culture medium containing drug concentrations of 0.5×MIC, 1×MIC and 2×MIC was prepared.
[0349] The test bacteria were diluted to the corresponding concentration, and samples were taken and diluted at 0 hours, 6 hours, and 24 hours, and then inoculated into nutrient agar medium.
[0350] After 24 hours of culture, the colonies were counted and a time-killing curve was drawn with time versus viable bacterial count (CFU / ml).
[0351] Experimental results:
[0352] MIC test results:
[0353]
[0354] Time-kill curve:
[0355]
[0356] Experimental summary:
[0357] Through the above experiments, the significant inhibitory effect of Qilianqinying Decoction on Helicobacter pylori at different concentrations and under different preparation conditions was verified. The specific results are as follows:
[0358] The minimum inhibitory concentration (MIC) of Example 1 is 25 g / L.
[0359] The minimum inhibitory concentration (MIC) of Example 2 is 30 g / L.
[0360] The minimum inhibitory concentration (MIC) of Example 3 is 35 g / L.
[0361] The minimum inhibitory concentration (MIC) of Example 4 is 27 g / L.
[0362] The minimum inhibitory concentration (MIC) of Example 5 was 32 g / L.
[0363] The time-killing curve showed that the antibacterial effect of Qilianqinying Decoction gradually increased over time, and a drug concentration of 2×MIC could completely kill Helicobacter pylori within 24 hours. The experimental results showed that Qilianqinying Decoction had a significant antibacterial effect on Helicobacter pylori in vitro, proving its potential as an effective Chinese medicine compound in the treatment of Helicobacter pylori.
[0364] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A method for inhibiting Helicobacter pylori with Qilianqinying Decoction, characterized in that: The following steps are involved: S1. Prepare Qilianqinying Decoction, which includes Astragalus, Coptis, Scutellaria, Pinellia, Magnolia and Taraxacum; S2. Prepare Qilianqinying Decoction according to a certain weight ratio range: S3, each Chinese herbal medicine slice is cut into small pieces and ground, soaked in water 8-12 times the volume of the herbal medicine for 1-2h, decocted three times, decocted for 25-35min, 25-35min and 15-25min respectively, filtered out the medicinal solution, combined, evaporated and concentrated at normal pressure until the ratio of the original medicinal material mass to the decoction volume is 1:1; S4. Determine the minimum inhibitory concentration of Qilianqinying Decoction against Helicobacter pylori by agar dilution method. The minimum inhibitory concentration is 25-35 g / L. S5. Dilute Helicobacter pylori to 0.4-0.6 McFarland turbidimetric units and then dilute again at a ratio of 1:5 to 1:15 to prepare three drug concentration culture media, inoculate and culture, take samples and dilute and inoculate at 0, 5-7, and 23-25 hours at 35-39°C, and count the colonies after culturing at 35-39°C for 22-26 hours.
2. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 1, characterized in that: In step S2, the Qilianqinying decoction is prepared according to the following weight ratio: 10-20g of Astragalus, 10-20g of Coptis, 10-20g of Scutellaria, 5-15g of Pinellia, 5-15g of Magnolia officinalis, and 10-30g of Taraxacum.
3. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 1, characterized in that: The S3 step specifically includes the following steps: S3.1, soaking: cut each Chinese herbal medicine into small pieces and grind them, and soak them in water 8-12 times the volume of the herbal medicine for 1-2 hours; S3.2, first decoction: decoct the soaked herbs for 25-35 minutes and filter out the liquid; S3.3, Second decoction: Add water to submerge the herbs by 3-4 cm, decoct for 25-35 min, and filter out the liquid; S3.4, third decoction: add water to submerge the herbs by 1-1.5cm, decoct for 15-25min, and filter out the liquid; S3.
5. Combination and concentration: Combine the three filtrates, evaporate at normal pressure, and concentrate until the ratio of the original medicinal material mass to the decoction volume is 1:
1.
4. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 1, characterized in that: The S4 step specifically includes the following steps: S4.
1. Prepare drug agar medium; S4.2, Inoculation of bacterial solution: The test bacteria were diluted to a concentration of 10 6 -10 8 CFU / ml bacterial suspension; Use a micropipette to draw 0.5-1.5 μl and inoculate it on the drug-containing plate. The final inoculation volume is about 10 3 -10 5 individual bacteria; S4.3, Cultivation and Observation: Incubate the plate upside down in a 35°C incubator for 16-20 hours; The lowest drug concentration at which no obvious bacterial growth was observed with the naked eye was defined as the minimum inhibitory concentration.
5. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 4, characterized in that: The preparation of the drug agar medium in step S4.1 specifically comprises the following steps: S4.
11. Prepare culture medium: Prepare several conical flasks and add 20-30 ml of melted broth agar medium to each flask; S4.12, dilution of the drug solution: Add 20-30ml of 100% Chinese herbal medicine decoction to the first flask to make the concentration 0.4-0.6g / ml; After mixing, take out 20-30 ml and add it to the second flask, and then dilute it in multiples until the required concentration range of 25-35 g / L is reached.
6. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 1, characterized in that: The step S5 specifically includes the following steps: S5.
1. Preparation of bacterial suspension: Take an appropriate amount of Helicobacter pylori standard strain and dilute it with sterile saline to 0.4-0.6 McFarland turbidimetric units and a bacterial count of 1.0-2.0×10 8 CFU / ml; Then dilute it at a ratio of 1:5 to 1:15 to make the bacterial count 1.0-2.0×10 7 CFU / ml for future use; S5.2, preparing three culture media with different drug concentrations; S5.
3. Inoculation and cultivation of bacterial suspension: Add an equal amount of bacterial suspension to each concentration of culture medium; Place in an incubator at 35-39°C; S5.4 Sampling and dilution: Samples were taken at 0 hours, 5-7 hours, and 23-25 hours; Dilute the sample at a ratio of 1:5 to 1:15; S5.
5. Inoculation and cultivation of diluted bacterial solution: Inoculate the diluted bacterial solution into nutrient agar medium; Spread evenly and incubate at 35-39℃ for 22-26h; S5.
6. Colony count: Colonies were counted after 22-26 hours of incubation.
7. The method for inhibiting Helicobacter pylori with Qilianqinying Decoction according to claim 6, characterized in that: The three culture media with different drug concentrations in step S5.2 are used to prepare broth culture media with drug concentrations of 0.4×MIC-0.6×MIC, 0.8×MIC-1.2×MIC and 1.8×MIC-2.2×MIC.
Citation Information
Patent Citations
Decoction for treating helicobacter pylori-associated gastritis
CN102145096A
Traditional Chinese medicine composition for treating helicobacter pylori infection, and preparation method and use thereof
CN113713031A
Anti-helicobacter pylori traditional Chinese medicine composition
CN114224989A
Uses of composition comprising polygonum capitatum and coptis roots in preparation of drugs for resisting against helicobacter pylori
WO2017020279A1
